The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint: Paris Tuesday, December 16, 2025, 11:00 Hrs [IST] Sanofi ...

The expanded partnership will give Equinox members preferred access to Function through exclusive pricing and program-integrated offerings that support long-term health. Equinox members will gain ...

Sanofi will conduct an impairment test in accordance with IFRS (IAS 36) on the intangible asset value attached to tolebrutinib with a status to be provided with Q4 and FY 2025 results in January 2026.

Soybean oil is regarded as beneficial to health, but this study suggests that you can have too much of a good thing and ...

The Department of National Defence is investing $120 million to clean up and remediate a site at the Jack Garland Airport in ...

These brain changes were connected with better metabolic health. As insulin resistance, leptin and other markers of ...

Two mutated alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in the autosomal recessive ...

Omeprazole is a widely used proton pump inhibitor that works by reducing the production of stomach acid, helping to treat and ...

Diabetes now affects about 529 million people worldwide, and roughly 1.6 million die from it each year. At the center of the ...

A full-term baby survived a rare abdominal pregnancy alongside the removal of a 22-pound ovarian tumor, defying nearly ...

A male in his 50s presented to the renal department with a diagnostic challenge of an unexplained kidney injury.